Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2012 February;67(1) > Minerva Chirurgica 2012 February;67(1):59-66





A Journal on Surgery

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877




Minerva Chirurgica 2012 February;67(1):59-66

language: Italian

“Skin reducing mastectomy” and immediate breast reconstruction with becker 35 contour profile breast implant: our experience

Chiummariello S., Arleo S., Pataia E., Iera M., Alfano C.

Struttura Complessa di Chirurgia Plastica e Ricostruttiva, Università di Perugia, Perugia, Italia


AIM:We describe in this paper our experience with the technique of skin-reducing mastectomy in the treatment of breast cancer.
METHODS:Between October 2005 and April 2010 in our Center 33 patients underwent breast surgery utilizing the skin-reducing mastectomy technique and immediate breast reconstruction with expansor/definitive implant Becker 35 contour profile. Contralateral symmetrization was performed in the same operation. All selected patients satisfied inclusion critera either for nipple-sparing mastectomy or prophylactic mastectomy. We selected patients who had large ptosic breasts: areola-submammary fold >8 cm and jugular-nipple distance >25 cm. After histologic exam to confirm the lack of retroareolar tissue infiltration the nipple was preserved in a superior flap.
RESULTS:Twenty-four out of 33 patients (72.7%) did not suffer from complications. In 9 patients (27.3%) we observed early complications. During follow-up we observed in24 patients (72.7%) Baker I capsular contracture, in 9 patients (27.3%) Baker II capsular contracture. Esthetic results of symmetry, shape and volume were good to optimal. Patients’ satisfaction was similar. During the follow up (6-33 months, average 17.7 months) no patient suffered from breast cancer recurrence.
CONCLUSION: The “skin-reducing mastectomy” reduces mutilation and unsightly scar visibility. It gives a pleasant aesthetic outcome without hindering oncological safety.

top of page

Publication History

Cite this article as

Corresponding author e-mail